Updated Jul 16, 2026
Eisner Mark has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $106K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-26 | VIR | Vir Biotechnology, Inc. | S — Open-market sale [10b5-1] | 1.9K | $9.82 | $19K |
| 2026-02-26 | VIR | Vir Biotechnology, Inc. | S — Open-market sale [10b5-1] | 1.6K | $9.53 | $15K |
| 2026-02-25 | VIR | Vir Biotechnology, Inc. | S — Open-market sale [10b5-1] | 2.1K | $7.45 | $16K |
| 2026-02-25 | VIR | Vir Biotechnology, Inc. | A — Grant or award [10b5-1] | 55.0K | $0.00 | |
| 2025-07-15 | VIR | Vir Biotechnology, Inc. | S — Open-market sale | 3.6K | $5.47 | $20K |
| 2025-07-15 | VIR | Vir Biotechnology, Inc. | S — Open-market sale | 6.8K | $5.47 | $37K |
Eisner Mark is a corporate insider — currently tracked as Insider of Jade Biosciences, Inc. (JBIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($106K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Eisner Mark profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.